Treatment selection in ductal carcinoma in situ

Breast Cancer

Volumn 8, Issue 4, 2001, Pages 275-282

  Morrow, Monica ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Intraductal carcinoma; Lumpectomy; Surgery

Indexed keywords

ADJUVANT THERAPY; ARTICLE; BREAST TUMOR; CARCINOMA IN SITU; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; MASTECTOMY; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEGMENTAL MASTECTOMY; SURVIVAL; TREATMENT OUTCOME;

BREAST NEOPLASMS; CARCINOMA IN SITU; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY; MASTECTOMY, SEGMENTAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0035749384     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967524     Document Type: Article

References (46)

1. Ernster VL, Barclay J, Kerlikowske K, et al: Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275:913-918, 1996. (Pubitemid 26095381)
2. Gapstur SM, Morrow M, Sellers TA: Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study. JAMA 281:2091-2097, 1999.
3. Sunshine JA, Moseley HS, Fletcher WS, et al: Breast carcinoma in situ. A retrospective review of 112 cases with a minimum 10-year follow-up. Am J Surg 150:44-51, 1985. (Pubitemid 15071746)
4. Von Rueden DG, Wilson RE: Intraductal carcinoma of the breast. Surg Gynecol Obstet 158:105-111, 1984. (Pubitemid 14181062)
5. Ashikari R, Huvos AG, Snyder RE: Prospective study of non-infiltrating carcinoma of the breast. Cancer 39:435-459, 1977.
6. Schuh ME, Nemoto T, Penetrante RB, et al: Intraductal carcinoma. Analysis of presentation, pathologic findings and outcome of disease. Arch Surg 121:1303-1307, 1986.
7. Kinne DW, Petrek JA, Osborne MP, et al: Breast carcinoma in situ. Arch Surg 124:33-36, 1984. (Pubitemid 19025899)
8. Silverstein MJ, Barth A Poller DN, et al: Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 31:1425-1427, 1995.
9. Ward BA, McKhann CF, Ravikumar TS: Ten-year follow-up of breast carcinoma in situ in Connecticut. Arch Surg 127:1392-1395, 1992.
10. Silverstein MJ, Poller DN, Waisman JR, et al: Prognostic classification of breast ductal carcinoma in situ. Lancet 345:1154-1157, 1995.
11. McCormick B, Rosen PP, Kinne D, et al: Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy. Int J Rad Oncol Biol Phys 21:289-292, 1991.
12. Silverstein MJ, Cohlan BF, Gierson ED, et al: Duct carcinoma in situ: 227 cases without microinvasion. Eur J Cancer 28:630-634, 1992.
13. Silverstein MJ, Lagios MD, Groshen S, et al: The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455-1461, 1999. (Pubitemid 29220544)
14. Ray GR, Adelson J, Hayhurst E, et al: Ductal carcinoma in situ of the breast: results of treatment by conservative surgery and definitive irradiation. Int J Radiat Oncol Biol Phys 28:105-11, 1993.
15. Hiramatsu H, Bornstein BA, Recht A, et al: Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ. Possible importance of family history. Cancer J Sci Am 1:55-61, 1995.
16. Fisher ER, Deeming R, Anderson S, et al: Conservative management of intraductal carcinoma (DCIS) of the breast. J Surg Oncol 47:139-147, 1991.
17. Stotter AT, McNeese M, Oswald MJ, et al: The role of limited surgery with irradiation in primary treatment of ductal in situ breast cancer. Int J Rad Oncol Biol Phys 18:283-287, 1990. (Pubitemid 20097520)
18. Solin LJ, Kurtz J, Fourquet A, et al: Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14:754-763, 1996. (Pubitemid 26085518)
19. Fisher B, Dignam J, Wolmark N, et al: Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16:441-452, 1998. (Pubitemid 28135585)
20. Julien JP, Bijker N, Fentiman IS, et al: Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase I trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 355:528-533, 2000. (Pubitemid 30088672)
21. Solin LJ, Fourquet A, McCormick B, et al: Salvage treatment for local recurrence following breast conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast. Int J Rad Oncol Biol Phys 309:3-9, 1994. (Pubitemid 24291107)
22. Solin IJ, McCormick B, Recht A, et al: Mammographically detected, clinically occult ductal carcinoma in situ (intraductal carcinoma) treated with breast conserving surgery and definitive irradiation. Cancer J Sci Am 2:158-165, 1996.
23. Carpenter R, Boulter PS, Cooke T, et al: Management of screen detected ductal carcinoma in situ of the female breast. Br J Surg 76:564-567, 1989. (Pubitemid 19155728)
24. Schwartz GF, Schwarting R, Cornfield DB, et al: Subclinical duct carcinoma in situ of the breast (DCIS): treatment by local excision and surveillance alone. Proc Am Soc Clin Oncol 15:101(abstract), 1996.
25. Baird RM, Worth A, Hislop G: Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breast. Am J Surg 159:479-481, 1990. (Pubitemid 20161004)
26. Araesson LG, Smeds S, Fagerberg G, et al: Follow-up of two treatment modalities for ductal carcinoma in situ of the breast. Br J Surg 76:672-675, 1989. (Pubitemid 19188768)
27. Gallagher WJ, Koerner FC, Wood WC: Treatment of intraductal carcinoma with limited surgery: long-term follow-up. J Clin Oncol 7:376-380, 1989. (Pubitemid 19075019)
28. Millis RR, Thynne GSJ: In situ intraductal carcinoma of the breast: a long-term follow-up study. Br J Surg 62:957-962, 1975.
29. Lagios MD: Excision only. Lagios experience. In: Silverstein MJ, ed, Ductal Carcinoma In Situ of the Breast, Williams and Wilkins, Baltimore, pp361-366, 1997.
30. Schwartz GF, Finkel GC, Garcia JC, et al: Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer 70:2468-2474, 1992.
31. Fisher B, Costantino J, Redmond C, et al: Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328:1581-1586, 1993. (Pubitemid 23151917)
32. Fisher ER, Dignam J, Tan-Chiu E, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86:429-438, 1999. (Pubitemid 29347405)
33. Page DL, Lagios MD: Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-17 trial. Unanswered questions remaining unanswered concerning current concepts of ductal carcinoma in situ. Cancer 75:1219-1222, 1995.
34. Holland R, Hendriks JHCL, Verbeek ALM, et al: Extent, distribution, and mammographic histological correlations of breast ductal carcinoma in situ. Lancet 335:519-522, 1990. (Pubitemid 20073065)
35. Holland R, Hendriks JHCL: Microcalcifications associated with ductal carcinoma in situ: mammographicpathologic correlation. Semin Diagn Pathol 11:181-192, 1994. (Pubitemid 24308078)
36. Morrow M, Schmidt R, Hassett C: Patient selection for breast conservation therapy with magnification mammography. Surgery 118:621-626, 1995.
37. Kearney TJ, Morrow M: Effect of reexcision on the success of breast-conserving surgery. Ann Surg Oncol 2:303-307, 1995.
38. Gluck BS, Dershaw DD, Liberman L, et al: Microcalcifications on postoperative mammograms as an indicator of adequacy of tumor excision. Radiology 188:469-472, 1993. (Pubitemid 23216273)
39. Waddell BE, Stamper PC, De Fazio JL, et al: Postexcision mammography is indicated after resection of ductal carcinoma-in-situ of the breast. Ann Surg Oncol 7:665-668, 2000.
40. Faverly D, Burgers L, Bult P, et al: Three-dimensional imaging of ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 11:193-198, 1994. (Pubitemid 24308079)
41. Morrow M, Venta LA, Stinson T, et al: A prospective comparison of stereotactic core biopsy and surgical excision as diagnostic procedures for breast cancer patients. Ann Surg 233:537-541, 2001. (Pubitemid 32234952)
42. Winchester DP, Strom EA: Standards for diagnosis and management of ductal carcinoma in situ (DOS) of the breast. CA Cancer J Clin 48:108-128, 1998. (Pubitemid 28122299)
43. Vicini FA, Kestin LL, Goldstein NS, et al: Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Clin Oncol 18:296-306, 2000. (Pubitemid 30056418)
44. Van Zee KJ, Liberman L, Samli B, et al: Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age. Cancer 86:1757-1767, 1999. (Pubitemid 29513045)
45. Fisher B, Dignam J, Wolmark N, et al: Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 353:1993-2000, 1999. (Pubitemid 29271743)
46. Szelei-Stevens KA, Kuske RR, Yantsos VA, et al: The influence of young age and positive family history of breast cancer on the prognosis of ductal carcinoma in situ treated by excision with or without radiation therapy or by mastectomy. Int J Radiat Oncol Biol Phys 48:943-949, 2000.